
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : BTL-TML-COVID
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Norwich Clinical Research Associates | Curavit Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
Details : BTL-TML-COVID is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 21, 2020
Lead Product(s) : BTL-TML-COVID
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Norwich Clinical Research Associates | Curavit Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Thimerosal
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Beech Tree Labs is Developing a Potential Antiviral Therapy to Fight COVID-19 Pandemic
Details : Beech Tree Labs sponsored two Phase 2 clinical trials that demonstrated the safety and efficacy of TML to reduce the onset of Herpes virus lesions after exposure to dental procedure or sunlight. The p value of the combined studies was 0.019. No adverse e...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 01, 2020
Lead Product(s) : Thimerosal
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : BTL-TML-HSV
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Norwich Clinical Research Associates | Hill Top Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
Details : BTL-TML-HSV is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Stomatitis, Herpetic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 18, 2013
Lead Product(s) : BTL-TML-HSV
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Norwich Clinical Research Associates | Hill Top Research
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : UISH001
Therapeutic Area : Urology
Study Phase : Phase I/ Phase II
Sponsor : Norwich Clinical Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence
Details : UISH001 is a drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Urinary Incontinence.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 22, 2011
Lead Product(s) : UISH001
Therapeutic Area : Urology
Highest Development Status : Phase I/ Phase II
Sponsor : Norwich Clinical Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : BTL-TML-HSV
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Norwich Clinical Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
Details : BTL-TML-HSV is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Stomatitis, Herpetic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 04, 2011
Lead Product(s) : BTL-TML-HSV
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Norwich Clinical Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
